US$ 27.99
base semaglutide | C187H291N45O59 | CID 56843331 π₯ A new study found
Description
R., Deluca, N., Fam, B
Side Effects Both medications share similar side effect profiles: Nausea (usually mild and temporary) Diarrhea or constipation Decreased appetite Fatigue during initial weeks Tirzepatide may cause slightly more gastrointestinal effects initially due to its dual-action mechanism, but most patients adapt within 2-4 weeks

This multi-receptor activity distinguishes it from earlier agents such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GLP-1/GIP agonist)

Imitating GIP can enhance the release of insulin, improve the metabolism of fat and boost fullness, typically wielding slightly higher weight loss results of an average of 15 percent body weight lost compared to Mounjaro's 20 percent average

Whether youre interested in small refinements or a more transformative result, our services aim to enhance your natural appearance

Medicine 1996;75(2):53-63 [PubMed: 8606627] 108
